Does tumor stroma ratio of breast cancer trucut biopsy determine response to neoadjuvant therapy?

Does tumor stroma ratio of breast cancer trucut biopsy determine response to neoadjuvant therapy?

Aims and Objectives: We examined the prognostic value of Tumor stroma ratio (TSR) in breast tumor core biopsy (TCB) specimen to determine response to neoadjuvant therapy (NAT) prior to modified radical mastectomy (MRM). Methods: This was a retrospective analysis of patients with breast cancer who un...

Full description

Bibliographic Details
Main Authors: Varuna Mallya, Vishal Singh, Navpreet Kaur, Priyanka Yadav, Shramana Mandal, Nita Khurana, Pawanindra Lal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
breast
neoadjuvant chemotherapy
residual cancer burden
tumor stroma ratio
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=5;spage=113;epage=116;aulast=Mallya

Internet

http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=5;spage=113;epage=116;aulast=Mallya

Similar Items